{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:51:46Z","timestamp":1786373506460,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2016,7]]},"abstract":"\n Background and objectives<\/jats:title>\n Atherosclerotic renal artery stenosis may cause kidney function loss, but effects of stenting on eGFR and clinical events associated with CKD are uncertain. Our study objectives were to determine effects of stenting on eGFR and predictors of clinical events.<\/jats:p>\n <\/jats:sec>\n \n Design, setting, participants, & measurements<\/jats:title>\n \n Participants (\n n<\/jats:italic>\n =931) in the Cardiovascular Outcomes in Renal Artery Stenosis Trial (from May of 2005 to September of 2012) had >60% atherosclerotic renal artery stenosis and systolic hypertension on two or more antihypertensive drugs and\/or stage \u22653 CKD. The intervention was stenting versus no stenting on a background of risk factor management: renin-angiotensin system inhibition, statin, antiplatelet therapy, and smoking cessation education. The effect of stenting on eGFR by the serum creatinine-cystatin C Chronic Kidney Disease Epidemiology Collaboration equation was the prespecified analysis of kidney function. Predictors of eGFR and CKD outcomes (\u226530% eGFR loss, ESRD, and death) and cardiovascular disease outcomes (stroke, myocardial infarction, heart failure, and death) controlling for eGFR and albuminuria were also determined.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n eGFR was 59\u00b124 ml\/min per 1.73 m\n 2<\/jats:sup>\n (mean\u00b1SD) at baseline. Over 3 years, eGFR change, assessed by generalized estimating equations, was \u22121.5\u00b17.0 ml\/min per 1.73 m\n 2<\/jats:sup>\n per year in the stent group versus \u22122.3\u00b16.3 ml\/min per 1.73 m\n 2<\/jats:sup>\n per year in the medical therapy only group (\n P<\/jats:italic>\n =0.18). eGFR predictors (multiple variable generalized estimating equations) were age, albuminuria, systolic BP, and diabetes (inverse associations) as well as men, total cholesterol, and HDL cholesterol (positive associations). CKD outcomes events occurred in 19% (175 of 931), and predictors (Cox proportional hazards models) included albuminuria (positive association), systolic BP (positive association), and HDL cholesterol (inverse association). Cardiovascular disease outcomes events occurred in 22% (207 of 931), and predictors included age, albuminuria, total cholesterol, prior cardiovascular disease, and bilateral atherosclerotic renal artery stenosis (positive associations).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Stenting did not influence eGFR in participants with atherosclerotic renal artery stenosis receiving renin-angiotensin system inhibition\u2013based therapy. Predictors of clinical events were traditional risk factors for CKD and cardiovascular disease.<\/jats:p>\n <\/jats:sec>","DOI":"10.2215\/cjn.10491015","type":"journal-article","created":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T22:54:40Z","timestamp":1464216880000},"page":"1180-1188","source":"Crossref","is-referenced-by-count":31,"title":["Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial"],"prefix":"10.2215","volume":"11","author":[{"given":"Katherine R.","family":"Tuttle","sequence":"first","affiliation":[{"name":"Providence Health Care, University of Washington, Spokane, Washington;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance D.","family":"Dworkin","sequence":"additional","affiliation":[{"name":"Brown University, Providence, Rhode Island;"},{"name":"Rhode Island Hospital, Providence, Rhode Island;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Henrich","sequence":"additional","affiliation":[{"name":"University of Texas Health Science Center, San Antonio, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Greco","sequence":"additional","affiliation":[{"name":"Baystate Health, Springfield, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Steffes","sequence":"additional","affiliation":[{"name":"University of Minnesota, Minneapolis, Minnesota;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon","family":"Tobe","sequence":"additional","affiliation":[{"name":"University of Toronto, Toronto, Ontario, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph I.","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Marshall University, Huntington, West Virginia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Jamerson","sequence":"additional","affiliation":[{"name":"University of Michigan, Ann Arbor, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asya","family":"Lyass","sequence":"additional","affiliation":[{"name":"Harvard Clinical Research Institute, Boston University, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Pencina","sequence":"additional","affiliation":[{"name":"Harvard Clinical Research Institute, Boston University, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Massaro","sequence":"additional","affiliation":[{"name":"Harvard Clinical Research Institute, Boston University, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph B.","family":"D\u2019Agostino","sequence":"additional","affiliation":[{"name":"Harvard Clinical Research Institute, Boston University, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald E.","family":"Cutlip","sequence":"additional","affiliation":[{"name":"Beth Israel Deaconess Medical Center, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy P.","family":"Murphy","sequence":"additional","affiliation":[{"name":"Brown University, Providence, Rhode Island;"},{"name":"Rhode Island Hospital, Providence, Rhode Island;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Cooper","sequence":"additional","affiliation":[{"name":"University of Toledo, Toledo, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2016,5,25]]},"reference":[{"key":"B1-20230816","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0025-6196(11)64210-9","article-title":"Outcomes of atherosclerotic renal artery stenosis managed without revascularization.","volume":"75","author":"Ch\u00e1bov\u00e1","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"B2-20230816","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1681\/ASN.V92252","article-title":"Survival in renal vascular disease.","volume":"9","author":"Conlon","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"B3-20230816","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/archinte.165.2.207","article-title":"Renovascular disease and the risk of adverse coronary events in the elderly: A prospective, population-based study.","volume":"165","author":"Edwards","year":"2005","journal-title":"Arch Intern Med"},{"key":"B4-20230816","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00041552-200411000-00006","article-title":"Atherosclerotic renal artery stenosis: Current status and future directions.","volume":"13","author":"Zalunardo","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B5-20230816","doi-asserted-by":"crossref","first-page":"840","DOI":"10.7326\/0003-4819-150-12-200906160-00119","article-title":"Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: A randomized trial.","volume":"150","author":"Bax","year":"2009","journal-title":"Ann Intern Med"},{"key":"B6-20230816","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa0905368","article-title":"Revascularization versus medical therapy for renal-artery stenosis.","volume":"361","author":"Wheatley","year":"2009","journal-title":"N Engl J Med"},{"key":"B7-20230816","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJM200004063421403","article-title":"The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis.","volume":"342","author":"van Jaarsveld","year":"2000","journal-title":"N Engl J Med"},{"key":"B8-20230816","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/01.HYP.31.3.823","article-title":"Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group.","volume":"31","author":"Plouin","year":"1998","journal-title":"Hypertension"},{"key":"B9-20230816","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/sj.jhh.1000599","article-title":"Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis.","volume":"12","author":"Webster","year":"1998","journal-title":"J Hum Hypertens"},{"key":"B10-20230816","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1310753","article-title":"Stenting and medical therapy for atherosclerotic renal-artery stenosis.","volume":"370","author":"Cooper","year":"2014","journal-title":"N Engl J Med"},{"key":"B11-20230816","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report.","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"B12-20230816","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).","volume":"285","year":"2001","journal-title":"JAMA"},{"issue":"Suppl 1","key":"B13-20230816","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease.","volume":"43","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 1","key":"B14-20230816","first-page":"S4","article-title":"Standards of medical care in diabetes\u20142006.","volume":"29","year":"2006","journal-title":"Diabetes Care"},{"key":"B15-20230816","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C.","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"key":"B16-20230816","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1681\/ASN.V1271475","article-title":"Long-term effects of arterial stenting on kidney function for patients with ostial atherosclerotic renal artery stenosis and renal insufficiency.","volume":"12","author":"Beutler","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"B17-20230816","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJM199702133360702","article-title":"Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty.","volume":"336","author":"Blum","year":"1997","journal-title":"N Engl J Med"},{"key":"B18-20230816","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0002-8703(00)90310-7","article-title":"Renal artery angioplasty and stent placement: Predictors of a favorable outcome.","volume":"139","author":"Burket","year":"2000","journal-title":"Am Heart J"},{"key":"B19-20230816","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/ajkd.2000.17654","article-title":"Revascularization of renal artery stenosis in patients with renal insufficiency.","volume":"36","author":"Dejani","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"B20-20230816","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0140-6736(96)10093-3","article-title":"Effect of renal-artery stenting on progression of renovascular renal failure.","volume":"349","author":"Harden","year":"1997","journal-title":"Lancet"},{"key":"B21-20230816","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1053\/ajkd.2002.29881","article-title":"Rapid decline in renal function reflects reversibility and predicts the outcome after angioplasty in renal artery stenosis.","volume":"39","author":"Muray","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"B22-20230816","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0002-9343(02)01396-7","article-title":"Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials.","volume":"114","author":"Nordmann","year":"2003","journal-title":"Am J Med"},{"key":"B23-20230816","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1093\/ndt\/14.6.1454","article-title":"Preservation of renal function by percutaneous transluminal angioplasty in ischaemic renal disease.","volume":"14","author":"Paulsen","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"B24-20230816","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0272-6386(98)70025-3","article-title":"Treatment of atherosclerotic ostial renal artery stenosis with the intravascular stent.","volume":"32","author":"Tuttle","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"B25-20230816","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.CIR.102.14.1671","article-title":"Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease.","volume":"102","author":"Watson","year":"2000","journal-title":"Circulation"},{"key":"B26-20230816","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199403313301301","article-title":"The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease.","volume":"330","author":"Klahr","year":"1994","journal-title":"N Engl J Med"},{"key":"B27-20230816","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1681\/ASN.V7102097","article-title":"Short-term effects of protein intake, blood pressure, and antihypertensive therapy on glomerular filtration rate in the Modification of Diet in Renal Disease Study.","volume":"7","author":"Levey","year":"1996","journal-title":"J Am Soc Nephrol"},{"issue":"2 Pt 2","key":"B28-20230816","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/01.HYP.37.2.774","article-title":"Combination of hypercholesterolemia and hypertension augments renal function abnormalities.","volume":"37","author":"Rodriguez-Porcel","year":"2001","journal-title":"Hypertension"},{"key":"B29-20230816","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/ndt\/gfu067","article-title":"Management of atherosclerotic renovascular disease after Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL).","volume":"30","author":"Herrmann","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"B30-20230816","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.ajkd.2013.07.020","article-title":"High-risk clinical presentations in atherosclerotic renovascular disease: Prognosis and response to renal artery revascularization.","volume":"63","author":"Ritchie","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"B31-20230816","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ccd.24449","article-title":"Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: Results from the HERCULES trial.","volume":"80","author":"Jaff","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"B32-20230816","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1053\/j.ajkd.2014.04.003","article-title":"What is the optimal treatment for patients with atherosclerotic renal artery stenosis?","volume":"64","author":"Greco","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"B33-20230816","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/CIRCINTERVENTIONS.110.960971","article-title":"Validity of estimated glomerular filtration rates for assessment of baseline and serial renal function in patients with atherosclerotic renal artery stenosis: Implications for clinical trials of renal revascularization.","volume":"4","author":"Madder","year":"2011","journal-title":"Circ Cardiovasc Interv"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201607000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:46:30Z","timestamp":1786369590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201607000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,25]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.10491015","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,25]]}}}